Welcome to our dedicated page for Farmland Partners SEC filings (Ticker: FPI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Farmland isn’t valued like office towers—and that’s why investors pore over Farmland Partners Inc’s SEC filings to track acreage prices, lease yields, and water-right assets. Yet combing through hundreds of pages to find those details can stall critical decisions.
Stock Titan surfaces the numbers that matter. Our AI-powered summaries translate every Farmland Partners annual report 10-K into plain English, highlight shifts in cropland valuations, and flag new risk factors—so you can stop scrolling and start analyzing. Need the latest cash-rent metrics hidden in a Farmland Partners quarterly earnings report 10-Q filing? We extract them instantly and compare them to prior quarters. Wondering about executive land purchases? Receive real-time alerts on Farmland Partners insider trading Form 4 transactions and drill into each Farmland Partners Form 4 insider transactions real-time feed without downloading a single PDF.
Every disclosure type is covered: 8-K material events explained when FPI buys contiguous acres, proxy statement executive compensation data that links bonuses to crop yields, and debt-agreement exhibits that detail farmland-backed credit lines. With AI-generated red-flag summaries, side-by-side quarter-over-quarter tables, and keyword search across filings, you’ll quickly answer questions like “How is FPI financing its newest Midwest acquisition?” or “What does the latest Farmland Partners earnings report filing analysis reveal about specialty-crop exposure?” Understanding Farmland Partners SEC documents with AI is no longer optional—it’s effortless.
On 7/22/25 Unity Biotechnology (UBX) entered into a Purchase Agreement with President/Secretary and sole director Craig R. Jalbert to sell a single Series A Preferred Share for $1. The share carries 600,000,000 votes but may be used only on the forthcoming Dissolution Proposal and must mirror the proportion of votes actually cast by common shareholders. It is non-convertible, pays a $0.01 priority dividend and automatically transfers back to the company after the stockholder meeting.
The step is designed to neutralise abstentions and broker non-votes, effectively lowering the practical approval hurdle for the board-approved dissolution plan announced 6/27/25. UBX’s common stock was suspended from Nasdaq on 7/9/25 and now trades on OTC Pink (UNBX); a Form 25 will be filed to delist. The issuance was made under the §4(a)(2) private-placement exemption. This 8-K/A otherwise only adds the former address to the cover page.
Atlassian (TEAM) Form 4: CEO, co-founder and 10% owner Michael Cannon-Brookes sold a total of 7,765 Class A shares on 22 Jul 2025 under a pre-arranged Rule 10b5-1 plan adopted 20 Feb 2025.
The stock was disposed of in seven separate trades at weighted-average prices between $195.965 and $202.35, generating roughly $1.55 million in gross proceeds. Following the sales, the insider—through CBC Co Pty Ltd as trustee of the Cannon-Brookes Head Trust—continues to hold 375,585 Class A shares, maintaining more than 98% of his prior indirect position and his 10% beneficial-owner status.
No derivative activity or purchases were reported. Given the modest 2% reduction in holdings and the existence of a 10b5-1 plan, the transactions appear routine and are unlikely to materially alter insider alignment, though any CEO liquidation can create short-term sentiment pressure.